Skip to main content

Seres Therapeutics Inc (NASDAQ: MCRB) Investor Securities Class Action Lawsuit 09/28/2016

  • If you purchased shares of Seres Therapeutics Inc (NASDAQ: MCRB), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

March 30, 2018 - The court granted defendants' motion to dismiss. March 30 - 2017 - A motion to dismiss the amended complaint was filed. February 13, 2017 - An amended complaint was filed. September 28, 2016 - An investor in shares of Seres Therapeutics Inc (NASDAQ: MCRB) filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Se...



You must register (for free) or login to view the entire case.